Texas Permanent School Fund’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-56,910
Closed -$2.02M 1288
2024
Q1
$2.02M Buy
56,910
+915
+2% +$24.5K 0.02% 1059
2023
Q4
$1.66M Buy
55,995
+961
+2% +$19.9K 0.01% 1120
2023
Q3
$1.14M Sell
55,034
-1,706
-3% -$46.9K 0.01% 1196
2023
Q2
$1.39M Sell
56,740
-789
-1% -$25.4K 0.01% 1137
2023
Q1
$2.34M Buy
57,529
+14,344
+33% +$594K 0.02% 878
2022
Q4
$1.94M Sell
43,185
-3,006
-7% -$136K 0.03% 782
2022
Q3
$2.21M Sell
46,191
-40
-0.1% -$2.19K 0.04% 676
2022
Q2
$2.74M Buy
46,231
+1,189
+3% +$97.6K 0.04% 579
2022
Q1
$5.24M Sell
45,042
-765
-2% -$89.3K 0.07% 299
2021
Q4
$6.89M Sell
45,807
-818
-2% -$110K 0.08% 219
2021
Q3
$5.57M Buy
+46,625
New +$5.14M 0.07% 305

Other funds holding TNDM

Texas Permanent School Fund's TNDM Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Tandem Diabetes Care (TNDM) in Q2 2024, closing a stake of 56,910 shares — an estimated $2.02M sold.

Texas Permanent School Fund first reported a position in TNDM in Q3 2021 and held it in 11 quarters. The position peaked at $6.89M in Q4 2021. 317 funds tracked by Wall St. Rank hold TNDM as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Tandem Diabetes Care position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 56,910 Tandem Diabetes Care shares in Q2 2024, an estimated $2.02M.
  • Texas Permanent School Fund first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 11 quarters.
  • Texas Permanent School Fund's Tandem Diabetes Care position peaked at $6.89M in Q4 2021.
  • 317 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.